Clinical Trials Directory

Trials / Completed

CompletedNCT00002670

Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery

Phase III Intergroup Trial of Surgery Followed by (1) Radiotherapy vs. (2) Radiochemotherapy For Resectable High Risk Squamous Cell Carcinoma of the Head and Neck

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
459 (actual)
Sponsor
Radiation Therapy Oncology Group · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether radiation therapy plus cisplatin is more effective than radiation therapy alone in treating patients with head and neck cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy plus cisplatin with radiation therapy alone in treating patients with head and neck cancer that has been removed during surgery.

Detailed description

OBJECTIVES: I. Evaluate locoregional control rates, patterns of first failure, and overall and disease-free survival in patients with advanced squamous cell carcinoma of the head and neck at high risk of locoregional recurrence who are treated postoperatively with concurrent cisplatin and radiotherapy. II. Compare the toxicity of concurrent chemoradiotherapy vs. radiotherapy alone in the postoperative setting. OUTLINE: Randomized study. Arm I: Radiotherapy. Involved-field irradiation using Co60, 1-6 MV photons, or electrons. Arm II: Radiotherapy plus Single-Agent Chemotherapy. Irradiation as in Arm I; plus Cisplatin, CDDP, NSC-119875. PROJECTED ACCRUAL: 438 patients will be entered over approximately 5 years.

Conditions

Interventions

TypeNameDescription
DRUGchemotherapy
DRUGcisplatin
RADIATIONlow-LET cobalt-60 gamma ray therapy
RADIATIONlow-LET electron therapy
RADIATIONlow-LET photon therapy

Timeline

Start date
1995-09-01
Primary completion
2002-07-01
Completion
2013-11-01
First posted
2004-06-10
Last updated
2014-01-24

Locations

23 sites across 2 countries: United States, South Africa

Source: ClinicalTrials.gov record NCT00002670. Inclusion in this directory is not an endorsement.